Evidence map›Paper›PMID 40366474›Full record

ArticleJournal of neurology2025

Cognitive impairment, mood, and fatigue in various multiple sclerosis subtypes: a one-year follow-up study.

Daniela Taranu, Luisa T Balz, Jill Holbrook, Visal Tumani, Herbert Schreiber, Hayrettin Tumani, Ingo Uttner

Abstract read
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniela Taranu *Department of Neurology, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.ORCID http://orcid.org/0000-0001-9165-4437
Luisa T Balz *Department of Neurology, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.
Jill HolbrookDepartment of Neurology, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.ORCID http://orcid.org/0009-0000-6403-6393
Visal TumaniDepartment of Psychiatry, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.ORCID http://orcid.org/0000-0002-8569-6638
Herbert SchreiberNeurological Practice Center, Neuropoint Academy & NTD, D-89073, Ulm, Germany.ORCID http://orcid.org/0000-0002-4755-492X
Hayrettin Tumani *Department of Neurology, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany. hayrettin.tumani@uni-ulm.de.ORCID http://orcid.org/0000-0002-1647-6201
Ingo Uttner *Department of Neurology, Faculty of Medicine, Ulm University, D-89071, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) subtypes-relapsing-remitting (RRMS), secondary-progressive (SPMS), and primary-progressive (PPMS) - have been associated with distinct cognitive impairment profiles, with progressive subtypes, in contrast to RRMS, showing additional deficits in more widespread domains. Research has largely focused on RRMS, leaving SPMS and PPMS underexplored due to their lower prevalence and limited therapeutic targeting. Data on the interplay between cognitive impairment, mood, and fatigue over time are also scarce. This study examined cognition, fatigue, and psychopathology over a period of one year to identify subtype-specific impairments and progression trajectories.

methodsSixty-six MS patients (22 each with RRMS, SPMS, and PPMS) and 22 healthy controls (HC) were assessed using neuropsychological tests for attention, memory, processing speed, working memory, fluency and visuospatial functions. Patient-reported outcomes for depression, anxiety, and fatigue were also collected. Analyses included correlations, within-group comparisons (paired t-tests), and between-group comparisons (ANOVAs/ANCOVAs).

resultsProgressive MS subtypes exhibited more severe cognitive impairments, fatigue, and mood disturbances than RRMS. Over one year, treated RRMS patients improved in various cognitive domains, while PPMS patients showed gains only in visuospatial abilities. On the other hand, SPMS patients exhibited no significant changes, suggesting more pronounced cognitive deficits.

conclusionsCognitive impairments differed significantly across MS subtypes. While RRMS patients improved over one year and PPMS patients showed selective gains in one domain, SPMS showed no significant changes, indicating reduced cognitive reserve. These between-group differences suggest different cognitive trajectories. The findings underscore the need for tailored, holistic interventions for different MS subtypes.

Indexed as

Cognitive DysfunctionFatigueMood DisordersMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingAdultDisease ProgressionFemaleFollow-Up StudiesHumansMaleMiddle AgedNeuropsychological TestsCognitive ImpairmentDisease ProgressionFatigueMultiple SclerosisNeuropsychological AssessmentPsychopathology

Identifiers

PMID40366474
PMCPMC12078348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.